Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2018 to Q4 2025

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
SLDB on Nasdaq
Shares outstanding
79,218,487
Price per share
$5.64
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
12,230
Total reported value
$75,459
% of total 13F portfolios
0%
Share change
+11,497
Value change
+$70,936
Number of holders
4
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $31,959,280 7,989,820 RA Capital Management, L.P. 19 Feb 2025
BCLS SB Investco, LP 7.8% $2,114,640 6,179,042 BCLS II Investco, LP 19 Feb 2025

As of 30 Sep 2025, 4 institutional investors reported holding 12,230 shares of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB). This represents 0.02% of the company’s total 79,218,487 outstanding shares.

Institutional Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 907 $5,115 -$62,723 $5.64 2
2025 Q3 12,230 $75,459 +$70,936 $6.17 4
2025 Q2 733 $3,569 +$1,352 $4.87 3
2025 Q1 478 $1,769 +$1,743 $3.71 3
2024 Q4 7 $28 $4.00 1
2024 Q3 7 $49 $0 $7.00 1
2024 Q2 7 $40 +$6 $5.71 1
2024 Q1 6 $80 $0 $13.33 1
2023 Q4 6 $37 $0 $6.17 1
2023 Q3 6 $15 -$346 $2.50 1
2023 Q2 72 $377 $0 $5.20 2
2023 Q1 72 $341 -$57,791 $4.70 2
2022 Q4 10,806 $58,136 -$29,082,189 $5.36 2
2022 Q3 62,882,363 $29,182,793 +$802,594 $0.47 47
2022 Q2 64,213,629 $39,528,533 -$5,527,570 $0.62 55
2022 Q1 69,162,095 $83,005,688 -$7,758,199 $1.20 70
2021 Q4 69,288,382 $121,236,834 -$8,133,770 $1.75 76
2021 Q3 76,886,323 $184,100,421 -$9,186,206 $2.39 86
2021 Q2 75,351,285 $275,650,775 -$5,732,808 $3.66 87
2021 Q1 79,127,101 $437,567,934 +$125,572,595 $5.53 103
2020 Q4 50,821,563 $385,189,843 +$228,503,748 $7.58 71
2020 Q3 25,430,770 $51,625,219 -$3,167,279 $2.03 54
2020 Q2 24,399,458 $71,489,131 +$20,123,396 $2.93 63
2020 Q1 18,761,459 $44,839,304 -$1,353,057 $2.39 68
2019 Q4 19,796,658 $88,091,790 -$123,567,079 $4.45 64
2019 Q3 32,102,068 $331,932,673 +$115,396,651 $10.34 68
2019 Q2 18,009,763 $103,470,745 +$19,659,380 $5.75 69
2019 Q1 16,703,653 $153,680,313 -$217,095,189 $9.20 72
2018 Q4 24,184,956 $648,159,427 +$128,910,279 $26.80 73
2018 Q3 18,605,082 $877,772,812 +$64,670,681 $47.18 76
2018 Q2 15,339,992 $545,242,685 +$93,274,588 $35.63 62
2018 Q1 15,597,572 $116,521,712 +$116,521,926 $7.50 55